David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UMPQ
1351
DELISTED
Umpqua Holdings Corp
UMPQ
| $4.32M | 0.01% |
272,153
+44,722
| +20% | +$675K |
|
1352
CALL
Devon Energy
DVN
$51.8B
| $4.31M | 0.01% |
157,100
-175,100
| -53% | -$4.26M |
|
1353
United Bankshares
UBSI
$6.47B
| $4.31M | 0.01% |
117,318
-5,551
| -5% | -$195K |
|
|
AF
1354
DELISTED
Astoria Financial Corporation
AF
| $4.28M | 0.01% |
270,102
-42,653
| -14% | -$646K |
|
1355
H&R Block
HRB
$6.44B
| $4.28M | 0.01% |
161,872
+112,338
| +227% | +$3.53M |
|
1356
Rexford Industrial Realty
REXR
$8.37B
| $4.26M | 0.01% |
234,754
-48,806
| -17% | -$820K |
|
|
IQNT
1357
DELISTED
Inteliquent, Inc.
IQNT
| $4.26M | 0.01% |
265,604
+86,313
| +48% | +$1.43M |
|
1358
Lumentum
LITE
$81.1B
| $4.26M | 0.01% |
157,892
-17,169
| -10% | -$397K |
|
|
NATI
1359
DELISTED
National Instruments Corp
NATI
| $4.26M | 0.01% |
141,400
+96,110
| +212% | +$2.76M |
|
1360
PUT
Coca-Cola
KO
$390B
| $4.25M | 0.01% |
91,700
-373,000
| -80% | -$16.2M |
|
|
NMBL
1361
DELISTED
Nimble Storage, Inc.
NMBL
| $4.25M | 0.01% |
541,955
+129,337
| +31% | +$920K |
|
|
NXTM
1362
DELISTED
NxStage Medical Inc.
NXTM
| $4.25M | 0.01% |
283,346
+4,658
| +2% | +$78.1K |
|
|
ACH
1363
Accendra Health
ACH
$90M
| $4.25M | 0.01% |
105,060
+72,788
| +226% | +$2.71M |
|
1364
Scorpio Tankers
STNG
$3.77B
| $4.24M | 0.01% |
72,772
+3,541
| +5% | +$210K |
|
1365
CALL
Bath & Body Works
BBWI
$3.68B
| $4.21M | 0.01% |
59,376
-60,489
| -50% | -$4.34M |
|
1366
PUT
Royal Gold
RGLD
$22.5B
| $4.21M | 0.01% |
82,100
-98,300
| -54% | -$4.01M |
|
|
NXGN
1367
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $4.2M | 0.01% |
275,618
+124,543
| +82% | +$1.89M |
|
1368
CALL
Ralph Lauren
RL
$21.5B
| $4.2M | 0.01% |
43,600
-25,200
| -37% | -$2.47M |
|
|
DEG
1369
DELISTED
ETABLISSEMENT DELHZ ADS 4 ADS REPTGS 1 ORD SHS
DEG
| $4.19M | 0.01% |
161,277
+83,572
| +108% | +$2.11M |
|
1370
PUT
Vale
VALE
$64.6B
| $4.17M | 0.01% |
990,100
-1,300,000
| -57% | -$4.04M |
|
1371
Cleveland-Cliffs
CLF
$6.62B
| $4.17M | 0.01% |
1,388,924
+243,446
| +21% | +$510K |
|
1372
Landstar System
LSTR
$6.13B
| $4.16M | 0.01% |
64,439
+19,570
| +44% | +$1.18M |
|
|
PARA
1373
CALL
DELISTED
Paramount Global Class B
PARA
| $4.15M | 0.01% |
75,400
-279,400
| -79% | -$13.6M |
|
|
SINA
1374
CALL
DELISTED
Sina Corp
SINA
| $4.15M | 0.01% |
87,700
-12,900
| -13% | -$580K |
|
1375
PUT
Ameriprise Financial
AMP
$49.4B
| $4.15M | 0.01% |
+44,100
| New | +$3.95M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.